Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental data

BACKGROUND: Antiangiogenic agents have been recently added to the oncological armamentarium with bevacizumab probably being the most popular representative in current clinical practice. The elucidation of the mode of action of these agents is a prerequisite for personalized prediction of antiangioge...

Descripción completa

Detalles Bibliográficos
Autores principales: Argyri, Katerina D., Dionysiou, Dimitra D., Misichroni, Fay D., Stamatakos, Georgios S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804544/
https://www.ncbi.nlm.nih.gov/pubmed/27005569
http://dx.doi.org/10.1186/s13062-016-0114-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804544/
https://www.ncbi.nlm.nih.gov/pubmed/27005569
http://dx.doi.org/10.1186/s13062-016-0114-9

Ejemplares similares